CTRI/2017/09/009828已完成未知
pharmacogenetics of tacrolimus in patients with kidney transplantation
Dr G Sirisha0 个研究点目标入组 80 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients of either gender, aged between 18-70 years and have undergone renal transplantation for end stage renal disease.
- •2.Patients on stable dose of tacrolimus (2-5 mg), with no change in the dose for at least two weeks.
- •3.Patients willing to give written informed consent
排除标准
- •1.Patients with co-morbid conditions such as hepatic insufficiency
- •2.Patients on other drugs which are likely to interact with immunosuppressive drugs.
- •3.Patients who suffered from gastrointestinal disease, liver disease or other disorders that may alter the absorption of tacrolimus.
研究者
相似试验
招募中
2 期
Effect of tacrolimus for patients with refractory Crohn's disease: A randomized, placebo-controlled trial.s diseaseCrohn's diseaseJPRN-UMIN000002796Department of Gastroenterology and Hepatology, Kyoto University50
尚未招募
不适用
Intra-Patient Variability of Tacrolimus in Kidney Transplant Patients at Bhumirajanagarindra Kidney Institute HospitalKidney Transplant patientsKidneyTransplantationTacrolimusVariabilityTCTR20210519005Bhumirajanagarindra Kidney Institute Hospital, Thailand100
进行中（未招募）
1 期
Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formulatiopediatric kidney transplant recipientsCTIS2024-511585-36-00Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)28
尚未招募
4 期
Personalized tacrolimus treatment for pediatric kidney transplant recipients by using a dosing algorithm and a once-daily tacrolimus formulation.NL-OMON51392Erasmus MC, Universitair Medisch Centrum Rotterdam28
招募中
不适用
Efficacy of tacrolimus in patients with refractory nephrotic syndromeRefractory nephrotic syndromeJPRN-UMIN000007089Department of Nephrology and Hypertension, Saitama Medical Center,Saitama Medical University20